Market Fallers: DS Smith, EVRAZ, Smith & Nephew, SSE

Broker Ratings

Stock in DS Smith ticker code: LON:SMDS has moved down -1.52% or -5.9 points in today’s trading session so far. Sellers have so far given a mostly negative outlook during the trading session. The period high has peaked at 387.1 while the low for the session was 381.15. The total volume of shares exchanged through this period comes to 434,650 with the daily average at 3,923,641. A 52 week high for the stock is 465.97 equating to 78.37 points difference from the previous close and the 52 week low at 271 a difference of some 116.6 points. The market capitalisation currently stands at £5,243.68m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for DS Smith being recorded at Friday, October 29, 2021 at 1:01:53 PM GMT with the stock price trading at 381.7 GBX.

Shares of EVRAZ with ticker code: LON:EVR has moved down -1.75% or -11 points in today’s trading session so far. Market sellers have not remained optimistic during the trading session. The periods high has already touched 633.2 meanwhile the session low reached 616.4. The total volume of shares traded by this point was 678,699 with the daily average at 2,333,774. The 52 week high price for the shares is 707.6 which comes in at 79.4 points difference from the previous days close and the 52 week low at 353.4 a difference of some 274.8 points. EVRAZ now has a 20 moving average of 613.46 and now a 50 day MA at 601.38. The market capitalisation is now £8,991.36m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for EVRAZ being recorded at Friday, October 29, 2021 at 1:01:42 PM GMT with the stock price trading at 617.2 GBX.

Stock in Smith & Nephew with company EPIC: LON:SN has decreased -3.79% or -48.85 points throughout today’s trading session so far. Sellers did not seem confident throughout the trading session. The periods high figure was 1274.52 and a low of 1234. The total volume of shares exchanged so far has reached 680,293 whilst the average number of shares exchanged is 2,522,768. A 52 week high for the stock is 1681.5 which is 393 points in difference to the previous days close of business and a 52 week low sitting at 1227 which is a variance of 61.5 points. The current market cap is £10,900.12m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Smith & Nephew being recorded at Friday, October 29, 2021 at 1:01:17 PM GMT with the stock price trading at 1239.65 GBX.

Shares of SSE ticker code: LON:SSE has stepped down -1.44% or -24.22 points during the course of today’s session so far. Investors have so far given a mostly negative outlook throughout the trading session. The periods high figure was 1679.5 dipping to 1648.5. The number of shares traded by this point in time totalled 475,554 with the daily average number around 3,349,206. A 52 week high for the stock is 1688.05 equating to 6.05 points difference from the previous days close and the 52 week low at 1238.42 which is a variance of 443.58 points. SSE now has a 20 simple moving average of 1604.05 and now the 50 day moving average of 1632.51. The market capitalisation currently stands at £17,663.56m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for SSE being recorded at Friday, October 29, 2021 at 1:02:25 PM GMT with the stock price trading at 1657.78 GBX.

Share on:

Latest Company News

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year targets and unveils a new $500m buyback program.

Smith & Nephew to host Surgeon Insights event in London

Smith & Nephew will host an investor event in London featuring US surgeons discussing innovation platforms across sports medicine, wound care, and orthopaedics, with presentations and Q&A sessions led by company leadership.

SSE updates market with higher FY2025/26 EPS guidance and continued investment growth

Ahead of full-year results on 28 May 2026, SSE said it expects adjusted EPS of 147–152 pence for the year ended 31 March 2026. The company also reported a sharp rise in networks investment, renewables output of around 14.5 TWh and capital investment of about £3.5bn.

Smith & Nephew delivers higher profits and cash generation in 2025

Smith+Nephew reported full-year 2025 revenue of $6.16 billion, up 6.1% on a reported basis, with trading profit rising 15.5% and free cash flow increasing 52.5%.

SSE Plc Q3 Trading Update: EPS Guidance Maintained

SSE plc reports strong Q3 performance for the nine months to 31 December 2025, with a 64% increase in regulated networks investment and renewable output up 7% year on year.

SSEN Transmission secures £1bn green loan for Scottish grid upgrades

SSEN Transmission has secured a £1 billion, 12-year bank facility backed by an £800 million guarantee from the UK Government’s National Wealth Fund to support four major grid upgrade projects in the north of Scotland.

    Search